BOLDSCIENCE
Divya Kernik has a diverse work experience in the medical and research fields. Starting in 2019, they worked as a Postdoctoral Research Fellow at Washington University in St. Louis, focusing on computational and experimental approaches to study drug effects in stem-cell derived cardiomyocytes. In 2021, they joined Ashfield MedComms, an Inizio Company, where they held two roles as an Associate Medical Writer and later as a Medical Writer. In 2022, they joined BOLDSCIENCE as a Senior Medical Writer.
Divya Kernik pursued their education in the field of Bioengineering and Biomedical Engineering. From 2014 to 2019, they attended the University of California, Davis, where they earned a Doctor of Philosophy (PhD) degree. Prior to that, they completed their Bachelor of Science (BS) in Biomedical/Medical Engineering from The Johns Hopkins University, attending from 2010 to 2014.
This person is not in any offices
BOLDSCIENCE
Boldscience creates communication programs for pharmaceutical clients that need a compelling voice to communicate to their audiences. They offer complete and integrated teams with industry experience to tackle accounts of any scale of service. Their scientific teams translate high science and jargon. Their scientific teams translate high scienceand jargon to tell stories that resonate with clients' audiences.